Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M. G. Kudryavtseva"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 322-327 (2019)
Aim. To study the effect of hyperglycemia on the total surface charge of the erythrocyte membrane (SCEM) in patients with metabolic syndrome (MS).Material and methods. 112 MS patients were examined (45 men and 67 women) (mean age 61.4±7.2 years, ave
Externí odkaz:
https://doaj.org/article/b4be3ca76a5b4e9f88dff7a01fb77a0b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 4, Pp 591-597 (2018)
The metabolic syndrome is a highly prevalent condition associated with increased cardiovascular risk in the population. Microvasculature is the terminal part of the cardiovascular system which primarily reacts to the increased secretion of the pro in
Externí odkaz:
https://doaj.org/article/906129188ec04d83ad9deaeb5671625a
Autor:
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 3, Pp 344-349 (2018)
Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS).Material and methods. 112 patients (mean age 61.4±7.2 years) with MS (average duration of MS 8.7±5.2 years) were examined. Control group consisted of healt
Externí odkaz:
https://doaj.org/article/5cd8f322d2184719bbaacc6c94cb06fb
Autor:
V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 2, Pp 184-189 (2018)
Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS) depending on glycemia levels. Material and methods. 112 patients (45 men and 67 women, age 61.4Ѓ}7.2 years) with MS (MS duration 8.7Ѓ}5.2 years) were studi
Externí odkaz:
https://doaj.org/article/51ecf4ccfcbf4d2f8f5b6688b8836e5a
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 70-75 (2019)
Aim. To study the level of “toxic” (Al, Cd, Pb) and “essential” (Fe, Cu, Zn, Co, Cr, Ni, and Se) trace elements (TE) and blood metals (BM) in patients with metabolic syndrome (MS), depending on its individual components. Materials and methods
Externí odkaz:
https://doaj.org/article/97c28a465e5b4d658124f097d64b682b
Autor:
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, A. I. Tarzimanova, M. G. Kudryavtseva, T. S. Vargina
Publikováno v:
Clinical Medicine (Russian Journal). 99:342-346
The development of microcirculatory disorders is considered to be one of the earliest changes in the cardiovascular system with a combination of arterial hypertension (AH) and obesity. The rheological properties of blood play a significant role in th
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 70-75 (2019)
Aim. To study the level of “toxic” (Al, Cd, Pb) and “essential” (Fe, Cu, Zn, Co, Cr, Ni, and Se) trace elements (TE) and blood metals (BM) in patients with metabolic syndrome (MS), depending on its individual components. Materials and methods
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 15, Iss 3, Pp 322-327 (2019)
Aim. To study the effect of hyperglycemia on the total surface charge of the erythrocyte membrane (SCEM) in patients with metabolic syndrome (MS).Material and methods. 112 MS patients were examined (45 men and 67 women) (mean age 61.4±7.2 years, ave
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 14, Iss 4, Pp 591-597 (2018)
The metabolic syndrome is a highly prevalent condition associated with increased cardiovascular risk in the population. Microvasculature is the terminal part of the cardiovascular system which primarily reacts to the increased secretion of the pro in
Autor:
M. G. Kudryavtseva, A. E. Bragina, T. V. Koroleva, Galina I. Bragina, Valery Podzolkov, M. V. Pisarev
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 14, Iss 3, Pp 344-349 (2018)
Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS).Material and methods. 112 patients (mean age 61.4±7.2 years) with MS (average duration of MS 8.7±5.2 years) were examined. Control group consisted of healt